{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T12:05:32Z","timestamp":1790337932963,"version":"4.1.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T00:00:00Z","timestamp":1784419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T00:00:00Z","timestamp":1784419200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Manipal Academy of Higher Education, Manipal","id":[{"id":"https:\/\/ror.org\/02xzytt36","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Otorhinolaryngol"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Hyperuricemia is a common metabolic condition with established systemic effects; however, its potential association with auditory dysfunction has not been clearly defined. This study aimed to evaluate hearing thresholds and cochlear outer hair cell function in individuals with hyperuricemia using subjective and objective audiological assessments.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A comparative cross-sectional study was conducted involving 130 participants aged 30\u201355 years, comprising 65 hyperuricemic subjects and 65 age- and gender-matched normouricemic controls. Pure Tone Audiometry (PTA) was performed at frequencies from 250 to 8000\u00a0Hz. Distortion Product Otoacoustic Emissions (DPOAE) were recorded at 1000, 2000, 4000, 6000, and 8000\u00a0Hz, and signal-to-noise ratio (SNR) values were analyzed. Statistical analysis included Student\u2019s t-test, Mann\u2013Whitney U test, and Chi-square test, with\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05 considered statistically significant.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Mean PTA thresholds were higher in hyperuricemic subjects across all tested frequencies compared to controls, with statistically significant differences (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Mild sensorineural hearing loss was more frequently observed in the hyperuricemic group. DPOAE analysis demonstrated significantly reduced SNR values, particularly at higher frequencies, and a higher proportion of absent emissions in hyperuricemic subjects. No significant association was observed between hearing loss and age or duration of symptoms.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The findings suggest an association between hyperuricemia and early cochlear dysfunction. Objective measures such as DPOAE may be useful for identifying subclinical auditory involvement in this population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00405-026-10426-2","type":"journal-article","created":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T19:50:55Z","timestamp":1784490655000},"page":"6371-6377","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hyperuricemia beyond gout: an emerging risk factor for sensorineural hearing loss"],"prefix":"10.1007","volume":"283","author":[{"given":"Gauri","family":"Govind","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2048-6373","authenticated-orcid":false,"given":"Vijendra S","family":"Shenoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neehal","family":"Zuturu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikrant","family":"Kamboj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haneesh","family":"Domah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanchit","family":"Bajpai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apoorva K","family":"V","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navya","family":"Parvathareddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nayanika","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashirwad","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,19]]},"reference":[{"key":"10426_CR1","unstructured":"George C, Leslie SW, Minter DA, Hyperuricemia (2023) Oct 14. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan\u2013. PMID: 29083565"},{"issue":"1","key":"10426_CR2","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/s41392-024-01916-y","volume":"9","author":"L Du","year":"2024","unstructured":"Du L, Zong Y, Li H, Wang Q, Xie L, Yang B, Pang Y, Zhang C, Zhong Z, Gao J (2024) Hyperuricemia and its related diseases: mechanisms and advances in therapy. Signal Transduct Target Ther 9(1):212. https:\/\/doi.org\/10.1038\/s41392-024-01916-y","journal-title":"Signal Transduct Target Ther"},{"issue":"13","key":"10426_CR3","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.2174\/1381612811319130011","volume":"19","author":"D Grassi","year":"2013","unstructured":"Grassi D, Ferri L, Desideri G, Di Giosia P, Cheli P, Del Pinto R, Properzi G, Ferri C (2013) Chronic hyperuricemia, uric acid deposit and cardiovascular risk. Curr Pharm Des 19(13):2432\u20132438. https:\/\/doi.org\/10.2174\/1381612811319130011","journal-title":"Curr Pharm Des"},{"issue":"1","key":"10426_CR4","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/HM9.0000000000000016","volume":"2","author":"L Liu","year":"2022","unstructured":"Liu L, Wang D, Liu M, Yu H, Chen Q, Wu Y, Bao R, Zhang Y, Wang T (2022) The development from hyperuricemia to gout: key mechanisms and natural products for treatment. Acupunct Herb Med 2(1):25\u201332. https:\/\/doi.org\/10.1097\/HM9.0000000000000016","journal-title":"Acupunct Herb Med"},{"issue":"8","key":"10426_CR5","doi-asserted-by":"publisher","first-page":"e022854","DOI":"10.1136\/bmjopen-2018-022854","volume":"8","author":"JA Singh","year":"2018","unstructured":"Singh JA, Cleveland JD (2018) Gout and hearing impairment in the elderly: a retrospective cohort study using the US Medicare claims data. BMJ Open 8(8):e022854. https:\/\/doi.org\/10.1136\/bmjopen-2018-022854","journal-title":"BMJ Open"},{"issue":"7","key":"10426_CR6","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.3390\/medicina59071273","volume":"59","author":"H Jeong","year":"2023","unstructured":"Jeong H, Chang YS, Jeon CH (2023) Association between Hyperuricemia and Hearing Impairment: Results from the Korean National Health and Nutrition Examination Survey. Med (Kaunas) 59(7):1273. https:\/\/doi.org\/10.3390\/medicina59071273","journal-title":"Med (Kaunas)"},{"issue":"1","key":"10426_CR7","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.semnephrol.2004.09.007","volume":"25","author":"J Kanellis","year":"2005","unstructured":"Kanellis J, Kang DH (2005) Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease. Semin Nephrol 25(1):39\u201342. https:\/\/doi.org\/10.1016\/j.semnephrol.2004.09.007","journal-title":"Semin Nephrol"},{"issue":"7081","key":"10426_CR8","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nature04516","volume":"440","author":"F Martinon","year":"2006","unstructured":"Martinon F, P\u00e9trilli V, Mayor A, Tardivel A, Tschopp J (2006) Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440(7081):237\u2013241. https:\/\/doi.org\/10.1038\/nature04516","journal-title":"Nature"},{"issue":"37","key":"10426_CR9","doi-asserted-by":"publisher","first-page":"E7766","DOI":"10.1073\/pnas.1702946114","volume":"114","author":"H Nakanishi","year":"2017","unstructured":"Nakanishi H, Kawashima Y, Kurima K, Chae JJ, Ross AM, Pinto-Patarroyo G, Patel SK, Muskett JA, Ratay JS, Chattaraj P, Park YH, Grevich S, Brewer CC, Hoa M, Kim HJ, Butman JA, Broderick L, Hoffman HM, Aksentijevich I, Kastner DL, Goldbach-Mansky R, Griffith AJ (2017) NLRP3 mutation and cochlear autoinflammation cause syndromic and nonsyndromic hearing loss DFNA34 responsive to anakinra therapy. Proc Natl Acad Sci U S A 114(37):E7766\u2013E7775. https:\/\/doi.org\/10.1073\/pnas.1702946114","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"32","key":"10426_CR10","doi-asserted-by":"publisher","first-page":"4145","DOI":"10.2174\/138161205774913255","volume":"11","author":"GK Glantzounis","year":"2005","unstructured":"Glantzounis GK, Tsimoyiannis EC, Kappas AM, Galaris DA (2005) Uric acid and oxidative stress. Curr Pharm Des 11(32):4145\u20134151. https:\/\/doi.org\/10.2174\/138161205774913255","journal-title":"Curr Pharm Des"},{"issue":"12","key":"10426_CR11","doi-asserted-by":"publisher","first-page":"493","DOI":"10.5923\/j.ajmms.20190912.10","volume":"9","author":"NM Abdelkader","year":"2019","unstructured":"Abdelkader NM, El-Sebaie A, Mohamed EF (2019) Effect of chronic gout on hearing: a prospective study. Am J Med Med Sci 9(12):493\u2013498. https:\/\/doi.org\/10.5923\/j.ajmms.20190912.10","journal-title":"Am J Med Med Sci"},{"issue":"1","key":"10426_CR12","doi-asserted-by":"publisher","first-page":"38","DOI":"10.61171\/v02.01.34","volume":"2","author":"M Shanawar","year":"2024","unstructured":"Shanawar M, Badar SA, Mehwish, Jabbar M, Cheema A, Shahzadi S et al (2024) Prevalence of hearing impairment among gout patients. Pioneer J Biostat Med Res 2(1):38\u201343","journal-title":"Pioneer J Biostat Med Res"},{"issue":"5","key":"10426_CR13","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1111\/coa.13950","volume":"47","author":"A Sahin","year":"2022","unstructured":"Sahin A, Kilic K, Sakat MS, Melikoglu MA, Sarihan K (2022) Early hearing loss detection in gout using extended high frequency audiometry. Clin Otolaryngol 47(5):577\u2013582. https:\/\/doi.org\/10.1111\/coa.13950","journal-title":"Clin Otolaryngol"},{"issue":"4","key":"10426_CR14","doi-asserted-by":"publisher","first-page":"226","DOI":"10.4103\/indianjotol.indianjotol_18_17","volume":"23","author":"A Saini","year":"2017","unstructured":"Saini A, Thakur JS, Saini G, Sharma DR, Mohindroo NK (2017) Hyperuricemia effects auditory functions. Indian J Otol 23(4):226\u2013229. https:\/\/doi.org\/10.4103\/indianjotol.indianjotol_18_17","journal-title":"Indian J Otol"},{"issue":"3","key":"10426_CR15","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.anl.2009.08.006","volume":"37","author":"AE S\u00fcsl\u00fc","year":"2010","unstructured":"S\u00fcsl\u00fc AE, Polat M, K\u00f6yba\u015fi S, Bi\u00e7er YO, Funda YO, Parlak AH (2010) Inner ear involvement in Beh\u00e7et\u2019s disease. Auris Nasus Larynx 37(3):286\u2013290. https:\/\/doi.org\/10.1016\/j.anl.2009.08.006","journal-title":"Auris Nasus Larynx"}],"container-title":["European Archives of Oto-Rhino-Laryngology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-026-10426-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00405-026-10426-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-026-10426-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T11:57:22Z","timestamp":1790337442000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00405-026-10426-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,19]]},"references-count":15,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10426"],"URL":"https:\/\/doi.org\/10.1007\/s00405-026-10426-2","relation":{},"ISSN":["0937-4477","1434-4726"],"issn-type":[{"value":"0937-4477","type":"print"},{"value":"1434-4726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,19]]},"assertion":[{"value":"9 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval was obtained through the Institution ethics committee, (IECKMCMLR- 11\/2023\/441)","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","label":"Informed Consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":3,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"During the preparation of this work, the author(s) utilized Large Language Models (LLM) solely to improve language and readability. The author(s) reviewed and edited the content as needed and take(s) full responsibility for the content of the publication.","order":4,"name":"Ethics","label":"Declaration of Large Language Model (LLM) Usage","group":{"name":"EthicsHeading","label":"Declarations"}}]}}